ATE46702T1 - 19-NOR STEROIDS SUBSTITUTED AT POSITION 11 AND OPTIONALLY AT POSITION 2, THEIR PREPARATION, THEIR UTILIZATION AS MEDICAMENTS, COMPOSITIONS CONTAINING THEM AND INTERMEDIATES OBTAINED

101 members in 32 offices

This recordMember, by publication datePriority claim22 more offices are in the list below

Priority claims1

Priority claims
Document	Office	Kind	Date
8210205	France	A	1982-06-11

Members101

Family members, oldest first
Document	Office	Kind
PT74263A	Portugal	A	1982-02-01
IE820044L	Ireland	L	1982-07-09
DK4082A	Denmark	A	1982-07-10
FI820042L	Finland	L	1982-07-10
AU7929682A	Australia	A	1982-07-15
FR2497807A1	France	A1	1982-07-16
EP0057115A2	European Patent Office (EPO)	A2	1982-08-04
EP0057115A3	European Patent Office (EPO)	A3	1982-09-29
JPS57168000A	Japan	A	1982-10-16
ZA8231B	South Africa	B	1982-11-24
ES508588A0	Spain	A0	1983-04-16
ES8305786A1	Spain	A1	1983-04-16
US4386085A	United States of America	A	1983-05-31
FR2497807B1	France	B1	1983-07-29
ES517764A0	Spain	A0	1983-12-01
ES8401498A1	Spain	A1	1983-12-01
FR2528434A1	France	A1	1983-12-16
EP0097572A1	European Patent Office (EPO)	A1	1984-01-04
KR840000581A	Republic of Korea	A	1984-02-25
JPS5946299A	Japan	A	1984-03-15
US4447424A	United States of America	A	1984-05-08
EP0110434A1	European Patent Office (EPO)	A1	1984-06-13
HU185158B	Hungary	B	1984-12-28
EP0057115B1	European Patent Office (EPO)	B1	1985-03-20
AT12239T	Austria	T	1985-04-15
ATE12239T1	Austria	T1	1985-04-15
DE3262580D1	Germany	D1	1985-04-25
US4519946A	United States of America	A	1985-05-28
FR2528434B1	France	B1	1985-07-19
CA1193246A	Canada	A	1985-09-10
US4547493A	United States of America	A	1985-10-15
CA1199907A	Canada	A	1986-01-28
AU550334B2	Australia	B2	1986-03-20
AU5123685A	Australia	A	1986-04-17
EP0196707A1	European Patent Office (EPO)	A1	1986-10-08
EP0110434B1	European Patent Office (EPO)	B1	1986-10-29
EP0097572B1	European Patent Office (EPO)	B1	1986-11-05
AT23167T	Austria	T	1986-11-15
AT23344T	Austria	T	1986-11-15
ATE23167T1	Austria	T1	1986-11-15
ATE23344T1	Austria	T1	1986-11-15
DE3273985D1	Germany	D1	1986-12-04
DE3367396D1	Germany	D1	1986-12-11
US4634695A	United States of America	A	1987-01-06
US4634696A	United States of America	A	1987-01-06
CA1220780A	Canada	A	1987-04-21
KR870001936B1	Republic of Korea	B1	1987-10-22
SG45987G	Singapore	G	1987-11-13
IE52595B1	Ireland	B1	1987-12-23
AU579211B2	Australia	B2	1988-11-17
SU1447289A3	Soviet Union (until 1991)	A3	1988-12-23
IT8848730A0	Italy	A0	1988-12-29
IT8848730D0	Italy	D0	1988-12-29
SE8804692D0	Sweden	D0	1988-12-29
FI77872B	Finland	B	1989-01-31
GB8830380D0	United Kingdom	D0	1989-03-01
FI77872C	Finland	C	1989-05-10
LU87417A1	Luxembourg	A1	1989-06-14
SE8804692L	Sweden	L	1989-07-01
FR2625505A2	France	A2	1989-07-07
DE3844408A1	Germany	A1	1989-07-13
NL8803196A	Netherlands (Kingdom of the)	A	1989-07-17
GB2213484A	United Kingdom	A	1989-08-16
JPH01213296A	Japan	A	1989-08-28
EP0196707B1	European Patent Office (EPO)	B1	1989-09-27
AT46702T	Austria	T	1989-10-15
ATE46702T1This record	Austria	T1	1989-10-15
DE3380628D1	Germany	D1	1989-11-02
JPH01279897A	Japan	A	1989-11-10
ES2012197A6	Spain	A6	1990-03-01
FR2640977A2	France	A2	1990-06-29
JPH0234958B2	Japan	B2	1990-08-07
US4978657A	United States of America	A	1990-12-18
CH676852A5	Switzerland	A5	1991-03-15
US5006518A	United States of America	A	1991-04-09
FR2625505B2	France	B2	1991-05-10
IL65680A	Israel	A	1991-06-30
US5043332A	United States of America	A	1991-08-27
GB2213484B	United Kingdom	B	1991-10-09
CA1303025C	Canada	C	1992-06-09
IT1235358B	Italy	B	1992-06-30
JPH0443077B2	Japan	B2	1992-07-15
JPH0466879B2	Japan	B2	1992-10-26
BE1004905A4	Belgium	A4	1993-02-23
ATA318788A	Austria	A	1993-04-15
DK166680B1	Denmark	B1	1993-06-28
AT396787B	Austria	B	1993-11-25
AR245730A1	Argentina	A1	1994-02-28
GR880100868A	Greece	A	1994-03-31
LT2618B	Lithuania	B	1994-04-25
MD207B1	Republic of Moldova	B1	1995-05-31
MD207C2	Republic of Moldova	C2	1995-12-31
BG60768B2	Bulgaria	B2	1996-02-29
SE503267C2	Sweden	C2	1996-04-29
GEP19960479B	Georgia	B	1996-07-22
JP2785023B2	Japan	B2	1998-08-13
DE19975073I1	Germany	I1	2000-03-09
NL300001I1	Netherlands (Kingdom of the)	I1	2000-04-03
NL300001I2	Netherlands (Kingdom of the)	I2	2000-08-01
DE3844408C2	Germany	C2	2001-07-26

Showing 100 of 101

2 legal events, as the office reported them to INPADOC

Over the term

Point at a mark for the event

Events

Legal events, newest first
	Event	Code
2003-09-15	Cancelled due to lapse of timeLapsedEELA	EELA
1990-03-15	Publication of translation of european patent specificationUEP	UEP

Numbers

Application: 86200441

Titles2

German: IN STELLUNG 11 UND 17 UND GEGEBENENFALLS IN STELLUNG 2 SUBSTITUIERTE 19-NOR-STEROIDE, IHRE HERSTELLUNG, IHRE ANWENDUNG ALS ARZNEIMITTEL, DIE SIE ENTHALTENDEN ZUSAMMENSETZUNGEN UND DIE ERHALTENEN ZWISCHENPRODUKTE.
English: SUBSTITUTED 19-NOR-STEROIDS IN POSITIONS 11 AND 17 AND, WHERE APPLICABLE, IN POSITION 2, THEIR MANUFACTURE, THEIR USE AS MEDICAMENTS, THE COMPOSITIONS CONTAINING THEM AND THE INTERMEDIATE PRODUCTS OBTAINED.

Classification

CPC, 10: C07J1/0088
C07J1/0059
C07J1/007
C07J21/006
C07J41/0077
C07J41/0083
C07J41/0094
C07J43/003
C07J71/0063
A61P5/38
Filled: the office’s first classification
IPC, 9: A61K31 565
A61K31 585
A61P5 38
C07J1 00
C07J21 00
C07J41 00
C07J43 00
C07J51 00
C07J71 00

19-nor steroids substituted at position 11 and optionally at position 2, their preparation, their utilization as medicaments, compositions containing them and intermediates obtained

Abstract

Term